Janssen Alzheimer Immunotherapy
Get Full AccessDescription
- Janssen Alzheimer Immunotherapy is a Pharmaceutical Research and Development subsidiary company of Johnson & Johnson. Its current focus is on Alzheimer Disease and recently (2012) completed a series of Phase 3 studies on its primary drug bapineuzumab.
-
Headquarters:700 Gateway Boulevard , South San Francisco, California, United States
More -
Phone Number: +1 650-794-2500
-
-
Employees:49
-
Revenue:$10 - 50M
-
Legal Name:Janssen Alzheimer Immunotherapy
-
Janssen Alzheimer Immunotherapy's Social Media
-
Is this data correct?
-
| NAICS Code: 624120 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Janssen Alzheimer Immunotherapy
-
Where are Janssen Alzheimer Immunotherapy's Headquarters?
Janssen Alzheimer Immunotherapy's Headquarters are in 700 Gateway Boulevard ,South San Francisco,California,United States
-
What is Janssen Alzheimer Immunotherapy's phone number?
Janssen Alzheimer Immunotherapy's phone number is +1 650-794-2500
-
What is Janssen Alzheimer Immunotherapy's Revenue?
Janssen Alzheimer Immunotherapy's revenue is $10 - 50M
-
What is Janssen Alzheimer Immunotherapy's NAICS code?
Janssen Alzheimer Immunotherapy's NAICS code is 624120
-
How many employees are working in Janssen Alzheimer Immunotherapy
Janssen Alzheimer Immunotherapy has 49 employees
-
What is Janssen Alzheimer Immunotherapy's Industry?
Janssen Alzheimer Immunotherapy is in the industry of Pharmaceuticals
-
Who is Janssen Alzheimer Immunotherapy's Director?
Janssen Alzheimer Immunotherapy's Director is Daniel Kidd
-
Who is Janssen Alzheimer Immunotherapy's District Business Director?
Janssen Alzheimer Immunotherapy's District Business Director is Dr.Razvan Munteanu